Imaging in targeted radiopharmaceuticals

There are several reasons why the use of PET imaging in the development of targeted radiopharmaceuticals offers many advantages. This whitepaper clearly demonstrates that PET imaging is an ideal, cost-effcient tool to follow up disease/therapy progression when studying the efficacy of newly developed targeted radiotherapies.

Download Whitepaper